CLINICAL_TRIALS
trial_result
· 2016-05-25
Clinical Trial Update: Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma [Phase 2]
Summary
Phase 2 study of pazopanib in patients with surgically unresectable or metastatic liposarcoma completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vector Oncology | Conditions: Liposarcoma, Surgically Unresectable Liposarcoma | Phase 2 | Status: COMPLETED | Results posted: 2016-05-25